NEUROFIBROMATOSIS MIDWEST (EIN 222580173) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

DIANA HABERKAMP

Phone

6309453562

Tax Period

2022-10-01 to 2023-09-30

NEUROFIBROMATOSIS MIDWEST, founded in 1981, is a small nonprofit in the Medical Research sector that reported $278K in total revenue in fiscal year 2017. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $323K exceeded revenue, resulting in a 16% operating deficit.

Mission

EDUCATION AND SUPPORT FOR THOSE WITH NEUROFIBROMATOSIS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $230,293

Program Service Revenue $0

Investment Income $7,244

Other Revenue $3,686

TOTAL REVENUE $241,223

Expense Breakdown

Grants Paid $60,282

Salaries & Benefits $116,338

Fundraising Expenses $27,938

Program Expenses $205,195

Other Expenses $85,968

TOTAL EXPENSES $262,588

Year-over-Year Comparison

	2022	2021	Change
Revenue	$241,223	$220,690	+0.1%
Expenses	$262,588	$218,142	+0.2%
Net Income	$-21,365	$2,548	-9.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENISE DULCEAK	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
DIANA HABERKAMP	EXECUTIVE DI	40.00	Officer Director	$0	$0	$0
GAIL MAVROGENES	BOARD MEMBER	1.00	Director	$0	$0	$0
ANDY RINGO	TREASURER	1.00	Officer Director	$0	$0	$0
LESLI WEGNER	VICE CHAIR	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$241,223	$262,588	$293,598	$-21,365
2022	$220,690	$218,142	$317,579	$2,548
2021	$209,965	$175,928	$351,353	$34,037
2020	$179,571	$214,976	$332,706	$-35,405
2019	$257,121	$209,751	$350,786	$47,370
2018	$277,690	$323,157	$296,479	$-45,467

NEUROFIBROMATOSIS MIDWEST